FDA approves ‘life-altering’ pancreatic cancer drug that nearly doubles life expectancy
26/08/2026-19:34 26/08/2026-19:35 חדשות New York Post דיווח
Daraxonrasib made headline earlier this year when former US Sen. Ben Sasse, R-Neb., shared details about his experience with the drug — which left his skin bloody and “bubbling” but is giving him more time with his family.
